270 related articles for article (PubMed ID: 7528184)
1. Intrathecal morphine in the treatment of chronic intractable pain.
Chambers FA; MacSullivan R
Ir J Med Sci; 1994 Jul; 163(7):318-21. PubMed ID: 7528184
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal morphine delivered via subcutaneous pump for intractable pain in pancreatic cancer.
Gilmer-Hill HS; Boggan JE; Smith KA; Frey CF; Wagner FC; Hein LJ
Surg Neurol; 1999 Jan; 51(1):6-11. PubMed ID: 9952116
[TBL] [Abstract][Full Text] [Related]
3. Chronic intrathecal morphine for intractable pain.
Penn RD; Paice JA
J Neurosurg; 1987 Aug; 67(2):182-6. PubMed ID: 3598678
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal administration of Infumorph® vs compounded morphine for treatment of intractable pain using the Prometra® programmable pump.
Rosen SM; Bromberg TA; Padda G; Barsa J; Dunbar E; Dwarakanath G; Navalgund Y; Jaffe T; Yearwood TL; Creamer M; Deer T
Pain Med; 2013 Jun; 14(6):865-73. PubMed ID: 23570280
[TBL] [Abstract][Full Text] [Related]
5. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy.
Kumar K; Kelly M; Pirlot T
Surg Neurol; 2001 Feb; 55(2):79-86; discussion 86-8. PubMed ID: 11301086
[TBL] [Abstract][Full Text] [Related]
6. Successful use of methadone in nociceptive cancer pain unresponsive to morphine.
Leng G; Finnegan MJ
Palliat Med; 1994; 8(2):153-5. PubMed ID: 7521715
[TBL] [Abstract][Full Text] [Related]
7. Intraventricular administration of morphine for control of intractable cancer pain in 90 patients.
Karavelis A; Foroglou G; Selviaridis P; Fountzilas G
Neurosurgery; 1996 Jul; 39(1):57-61; discussion 61-2. PubMed ID: 8805140
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal narcotics for relief of pain from head and neck cancer.
Andersen PE; Cohen JI; Everts EC; Bedder MD; Burchiel KJ
Arch Otolaryngol Head Neck Surg; 1991 Nov; 117(11):1277-80. PubMed ID: 1747233
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival.
Ripamonti C; Brunelli C
J Clin Oncol; 2003 Jul; 21(14):2801-2; author reply 2802-3. PubMed ID: 12860959
[No Abstract] [Full Text] [Related]
10. [Treatment of severe cancer pain via spinal catheters].
Andersen JS; Markers PI; Valentin N
Ugeskr Laeger; 1996 Nov; 158(46):6613-6. PubMed ID: 8966828
[TBL] [Abstract][Full Text] [Related]
11. Constant infusion of morphine for intractable cancer pain using an implanted pump.
Hassenbusch SJ; Pillay PK; Magdinec M; Currie K; Bay JW; Covington EC; Tomaszewski MZ
J Neurosurg; 1990 Sep; 73(3):405-9. PubMed ID: 2384779
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal morphine infusion for intractable cancer pain: a new use for implanted pumps.
Paice JA
Oncol Nurs Forum; 1986; 13(3):41-7. PubMed ID: 3635136
[No Abstract] [Full Text] [Related]
13. Management of intractable pain in cancer patients by implantable morphine infusion systems.
Dennis GC; DeWitty R
J Natl Med Assoc; 1987 Sep; 79(9):939-44. PubMed ID: 3669090
[TBL] [Abstract][Full Text] [Related]
14. Continuous intrathecal analgesia with opioid/local anaesthetic mixture for cancer pain.
Goucke R
Anaesth Intensive Care; 1993 Apr; 21(2):222-3. PubMed ID: 8517518
[No Abstract] [Full Text] [Related]
15. Long-term intrathecal infusion of morphine in the home care of patients with advanced cancer.
Gestin Y; Vainio A; Pégurier AM
Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 1):12-7. PubMed ID: 9061109
[TBL] [Abstract][Full Text] [Related]
16. Management of patients with pain and severe side effects while on intrathecal morphine therapy: A case study.
Zhou K; Sheng S; Wang GG
Scand J Pain; 2017 Oct; 17():37-40. PubMed ID: 28850371
[TBL] [Abstract][Full Text] [Related]
17. Intraspinal delivery of opiates by an implantable, programmable pump in patients with chronic, intractable pain of nonmalignant origin.
Kanoff RB
J Am Osteopath Assoc; 1994 Jun; 94(6):487-93. PubMed ID: 8077118
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.
Lin CP; Lin WY; Lin FS; Lee YS; Jeng CS; Sun WZ
J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395
[TBL] [Abstract][Full Text] [Related]
19. Sufentanil citrate and morphine/bupivacaine as alternative agents in chronic epidural infusions for intractable non-cancer pain.
Hassenbusch SJ; Stanton-Hicks MD; Soukup J; Covington EC; Boland MB
Neurosurgery; 1991 Jul; 29(1):76-81; discussion 81-2. PubMed ID: 1831248
[TBL] [Abstract][Full Text] [Related]
20. Drug-related side effects of long-term intrathecal morphine therapy.
Ruan X
Pain Physician; 2007 Mar; 10(2):357-66. PubMed ID: 17387357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]